Transplant News and Research

RSS

Viewpoints: Vinson's backdown, Ariz. Death Panels and The Pentagon's Achilles' heel

A federal district judge in Florida backed down, as he should have, from his effort to bully the Obama administration into halting implementation of the new health care reforms even before the issue of the law's constitutionality is resolved by higher courts.

11 Mar 2011

Positive results from exenatide phase 2 study in patients with type 2 diabetes

Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced positive results from a phase 2 study evaluating the effects of a once-monthly injectable suspension formulation of exenatide on glycemic control in patients with type 2 diabetes.

10 Mar 2011

CTI announces final pixantrone clinical trial design for treatment of DLBCL

Cell Therapeutics, Inc. today announced the final clinical trial design of a randomized pivotal trial of pixantrone for the treatment of diffuse large B-cell lymphoma following discussions with the U.S. Food and Drug Administration's Division of Hematologic Products.

10 Mar 2011

Cedars-Sinai earns excellence in 2010 adult heart transplants

The Cedars-Sinai Heart Institute and Comprehensive Transplant Center performed the most adult heart transplants of any U.S. medical center in 2010, according to government statistics released today.

10 Mar 2011

Study: Alcohol abuse impacts quality of life for patients after liver transplant

A history of alcohol abuse significantly impacts quality of life for patients after liver transplant, according to researchers at Henry Ford Hospital.

10 Mar 2011

CUBN gene mutation linked with albuminuria in individuals with or without diabetes

A team of researchers from the United States and Europe has identified a single genetic mutation in the CUBN gene that is associated with albuminuria both with and without diabetes. Albuminuria is a condition caused by the leaking of the protein albumin into the urine, which is an indication of kidney disease.

9 Mar 2011

Viewpoints: Are waivers weakening health law?; Ill. 'Dangerous Docs'; Arizona transplants

It is irresponsible for the feds to dole out hundreds of millions without the assurance of insurance, payment and system reform, as well as universal coverage. That's the problem with Republican proposals to use a "block grant" approach in giving Medicaid dollars to the states to do with as they will. The president should use his precious time to encourage the law's implementation as soon as possible in areas of the country that are already on this road -- like our own Upper Midwest -- not to coddle his political enemies.

9 Mar 2011

LUMEDX implements HealthView Chest Pain Management solution at Methodist hospitals

LUMEDX Corporation, a leading provider of fully integrated, vendor-neutral cardiovascular imaging and information systems, announced today that it has begun implementing the HealthView Chest Pain Management solution at five Methodist Healthcare facilities in San Antonio, Texas.

9 Mar 2011

Merck to present VICTRELIS phase III study data against HCV at EASL annual meeting

Merck, known as MSD outside of the United States and Canada, announced that several new data analyses from Phase III studies of VICTRELIS, its investigational oral hepatitis C protease inhibitor, will be presented at The International Liver CongressTM / 46th European Association for the Study of the Liver annual meeting.

9 Mar 2011

First hand transplant recipient on the way to recovery

A 26 year old mother has received the world’s first hand transplant. The 17 member surgical team from the Hand Transplant Program at Ronald Reagan UCLA Medical Center has performed the operation over 14 hours. They painstakingly attached tendons, blood vessels and nerves. The patient had lost her hand in a traffic accident 5 years ago. The patient is currently recovering.

8 Mar 2011

Lab made urinary tube going strong after six years of transplant

In a scientific breakthrough, five boys who were unable to urinate due to pelvic injury were cured for up to six years after getting new lab-grown urethras or urinary tubes that connect with the bladder. This breakthrough comes from Wake Forest University researcher Anthony Atala. It was in 2006 that the team reported the first successful implantation of lab-grown urinary bladders into humans. Today six years after the operation all of the boys continue to do well, with normal or near-normal urinary flow. The boy first treated is now 16 years old and received his lab-grown urethra over six years ago.

8 Mar 2011

Researchers develop new method for DNA sequencing analysis

Up to today, researchers have been limited to running just a few DNA samples at a time, at a cost of SEK 100,000 per run. Now researchers at the Royal Institute of Technology in Stockholm have hit upon a new method that allows 5,000 samples to be run at the same time and at the same price.

8 Mar 2011

First western U.S. hand transplant surgery performed at UCLA Medical Center

Surgeons at Ronald Reagan UCLA Medical Center performed the first hand transplant in the western United States in an operation that began one minute before midnight on Friday, March 4, and was completed 14-and-a-half hours later, on Saturday, March 5.

8 Mar 2011

hUCBs and MenSCs transplant may offer future therapeutic benefit for AD, stroke, ALS

Transplanting stem cells derived from umbilical cord blood cells and menstrual blood cells may offer future therapeutic benefit for those suffering from stroke, Alzheimer's disease, and amyotrophic lateral sclerosis, says a team of neuroscience researchers from the University of South Florida's Department of Neurosurgery and Brain Repair and collaborators from three private-sector research groups, Saneron CCEL Therapeutics, Inc., Tampa, FL, Cryo-Cell International, Inc., Oldsmar, FL, and Cryopraxis, Cell Praxis, BioRio, Rio de Janeiro, Brazil.

8 Mar 2011

State roundup: Mass. effort to manage care for chronically ill; promoting organ donations

For a glimpse of the future of Massachusetts health care as Gov. Deval Patrick envisions it, consider Phyllis Minsky. At 82, Phyllis is complex. Medically, that is. ... Older patients with multiple chronic diseases are the biggest consumers of health care; some 15 percent of Medicare patients make up over 75 percent of health care spending.

8 Mar 2011

First implantable heart transplant using new LVAD performed at University of Utah Hospital

Surgeons at University of Utah Hospital have performed the hospital's first implant of a new-generation left ventricular assist device using the HeartWare HVAD. The tiny, partial artificial heart device is being used as part of a national research study for patients with advanced heart failure who are not candidates for heart transplantation.

5 Mar 2011

Pfizer's ORAL Sync Phase 3 study of tofacitinib in moderate-to-severe RA meets primary endpoints

Pfizer Inc. today announced that the ORAL Sync Phase 3 study of tofacitinib, formerly known as tasocitinib, an investigational, novel, oral JAK inhibitor, being studied in moderate-to-severe rheumatoid arthritis, met its primary endpoints by showing statistically significant changes versus placebo in reducing signs and symptoms of RA, as measured by ACR20 response rates at six months; in improving physical function, as measured by mean change in HAQ DI at three months; and in reaching DAS28-4 <2.6 at six months.

5 Mar 2011

Viewpoints: Gambling on entitlement cuts; 'culture war' over family planning; insurance premium 'gouge' in Calif.

The House Republicans are rolling the political dice. They've pledged that in their budget for next year they will offer detailed proposals for curbing spending on "entitlements" — Social Security, Medicare and Medicaid. When Democrats heard this, their world suddenly brightened. One congressional aide dismissed the Republicans as "suckers".

4 Mar 2011

ThermoGenesis prices offering of 2,250,000 shares of common stock

ThermoGenesis Corp., a leading supplier of innovative products and services that process and store adult stem cells, said today that it has determined the pricing for an offering of shares and warrants.

4 Mar 2011

Sangamo's preclinical ZFN-gene modification studies for HIV/AIDS treatment presented at CROI

Sangamo BioSciences, Inc. announced that data from its programs to develop ZFN-based therapeutic approaches for the treatment of HIV/AIDS were discussed in four oral presentations at the 18th Conference on Retroviruses and Opportunistic Infections, held in Boston from February 27 to March 2, 2011.

4 Mar 2011

Transplant News and Research

Viewpoints: Vinson's backdown, Ariz. Death Panels and The Pentagon's Achilles' heel

Positive results from exenatide phase 2 study in patients with type 2 diabetes

CTI announces final pixantrone clinical trial design for treatment of DLBCL

Cedars-Sinai earns excellence in 2010 adult heart transplants

Study: Alcohol abuse impacts quality of life for patients after liver transplant

CUBN gene mutation linked with albuminuria in individuals with or without diabetes

Viewpoints: Are waivers weakening health law?; Ill. 'Dangerous Docs'; Arizona transplants

LUMEDX implements HealthView Chest Pain Management solution at Methodist hospitals

Merck to present VICTRELIS phase III study data against HCV at EASL annual meeting

First hand transplant recipient on the way to recovery

Lab made urinary tube going strong after six years of transplant

Researchers develop new method for DNA sequencing analysis

First western U.S. hand transplant surgery performed at UCLA Medical Center

hUCBs and MenSCs transplant may offer future therapeutic benefit for AD, stroke, ALS

State roundup: Mass. effort to manage care for chronically ill; promoting organ donations

First implantable heart transplant using new LVAD performed at University of Utah Hospital

Pfizer's ORAL Sync Phase 3 study of tofacitinib in moderate-to-severe RA meets primary endpoints

Viewpoints: Gambling on entitlement cuts; 'culture war' over family planning; insurance premium 'gouge' in Calif.

ThermoGenesis prices offering of 2,250,000 shares of common stock

Sangamo's preclinical ZFN-gene modification studies for HIV/AIDS treatment presented at CROI

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News